HILARY DULIN SAUTA: Open Payments
NPI 1790202885 · AUBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$205 in 9 payments from 6 companies in 2025. Trend: 2023 $143 · 2024 $206 · 2025 $205
Food & beverage: $205
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $75 |
| Novo Nordisk Inc | 2 | $41 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Averitas Pharma Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $16 |
Products named: ERLEADA, Ozempic, TREMFYA, ENTYVIO, KEYTRUDA, QUTENZA, NEXLETOL.
Industry payments across MA — which companies pay providers there.
